Court Upholds FDA's Approval of Avadel's Lumryz Over Jazz's Xywav in Orphan Drug Exclusivity Dispute
A U.S. District Court upheld the FDA's decision to approve Avadel's Lumryz, a once-nightly sodium oxybate formulation, for narcolepsy.
© Copyright 2025. All Rights Reserved by MedPath